Cargando…
Cannabis sativa CBD Extract Exhibits Synergy with Broad-Spectrum Antibiotics against Salmonella enterica subsp. Enterica serovar typhimurium
New generation antibiotics are needed to combat the development of resistance to antimicrobials. One of the most promising new classes of antibiotics is cannabidiol (CBD). It is a non-toxic and low-resistance chemical that can be used to treat bacterial infections. The antibacterial activity of Cann...
Autores principales: | Gildea, Logan, Ayariga, Joseph Atia, Xu, Junhuan, Villafane, Robert, Robertson, Boakai K., Samuel-Foo, Michelle, Ajayi, Olufemi S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784314/ https://www.ncbi.nlm.nih.gov/pubmed/36557613 http://dx.doi.org/10.3390/microorganisms10122360 |
Ejemplares similares
-
Cannabis sativa CBD Extract Shows Promising Antibacterial Activity against Salmonella typhimurium and S. newington
por: Gildea, Logan, et al.
Publicado: (2022) -
CBD resistant Salmonella strains are susceptible to epsilon 34 phage tailspike protein
por: Ibrahim, Iddrisu, et al.
Publicado: (2023) -
Draft Genome Sequence of Salmonella enterica subsp. enterica Serovar Typhimurium Q1
por: Eichhorn, Inga, et al.
Publicado: (2017) -
Molecular differentiation between Salmonella enterica subsp enterica serovar Pullorum and Salmonella enterica subsp enterica serovar Gallinarum
por: Ribeiro, Simone Alves Mendes, et al.
Publicado: (2009) -
Transcriptomic data of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S treated with novobiocin
por: Gogoleva, Natalia E., et al.
Publicado: (2020)